• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

计算心肺成像和理想化的肺清除指数(iLCI)在早期囊性纤维化中的应用。

Computed cardiopulmonography and the idealized lung clearance index, iLCI, in early-stage cystic fibrosis.

机构信息

Department of Chemistry, University of Oxford, Oxford, United Kingdom.

Royal Brompton and Harefield Hospitals, Guys and St Thomas' Trust, London, United Kingdom.

出版信息

J Appl Physiol (1985). 2023 Jul 1;135(1):205-216. doi: 10.1152/japplphysiol.00744.2022. Epub 2023 Jun 1.

DOI:10.1152/japplphysiol.00744.2022
PMID:37262105
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10393329/
Abstract

This study explored the use of computed cardiopulmonography (CCP) to assess lung function in early-stage cystic fibrosis (CF). CCP has two components. The first is a particularly accurate technique for measuring gas exchange. The second is a computational cardiopulmonary model where patient-specific parameters can be estimated from the measurements of gas exchange. Twenty-five participants (14 healthy controls, 11 early-stage CF) were studied with CCP. They were also studied with a standard clinical protocol to measure the lung clearance index (LCI). Ventilation inhomogeneity, as quantified through CCP parameter σlnCl, was significantly greater ( < 0.005) in CF than in controls, and anatomical deadspace relative to predicted functional residual capacity (DS/FRCpred) was significantly more variable ( < 0.002). Participant-specific parameters were used with the CCP model to calculate idealized values for LCI (iLCI) where extrapulmonary influences on the LCI, such as breathing pattern, had all been standardized. Both LCI and iLCI distinguished clearly between CF and control participants. LCI values were mostly higher than iLCI values in a manner dependent on the participant's respiratory rate (r = 0.46, < 0.05). The within-participant reproducibility for iLCI appeared better than for LCI, but this did not reach statistical significance ( ratio = 2.2, = 0.056). Both a sensitivity analysis on iLCI and a regression analysis on LCI revealed that these depended primarily on an interactive term between CCP parameters of the form σlnCL*(DS/FRC). In conclusion, the LCI (or iLCI) probably reflects an amalgam of different underlying lung changes in early-stage CF that would require a multiparameter approach, such as potentially CCP, to resolve. Computed cardiopulmonography is a new technique comprising a highly accurate sensor for measuring respiratory gas exchange coupled with a cardiopulmonary model that is used to identify a set of patient-specific characteristics of the lung. Here, we show that this technique can improve on a standard clinical approach for lung function testing in cystic fibrosis. Most particularly, an approach incorporating multiple model parameters can potentially separate different aspects of pathological change in this disease.

摘要

本研究探讨了使用计算心肺图(CCP)评估早期囊性纤维化(CF)患者的肺功能。CCP 有两个组成部分。第一部分是一种特别准确的气体交换测量技术。第二部分是一个计算心肺模型,可以从气体交换的测量中估计患者特定的参数。25 名参与者(14 名健康对照者,11 名早期 CF 患者)接受了 CCP 研究。他们还接受了标准临床方案来测量肺清除指数(LCI)。通过 CCP 参数 σlnCl 量化的通气不均匀性在 CF 患者中明显大于(<0.005)对照组,并且解剖死腔与预测功能残气量(DS/FRCpred)的比值明显更可变(<0.002)。使用 CCP 模型和参与者特定的参数来计算 LCI 的理想值(iLCI),其中对 LCI 的肺外影响,例如呼吸模式,都已标准化。LCI 和 iLCI 都清楚地区分了 CF 和对照组参与者。LCI 值在很大程度上高于 iLCI 值,这与参与者的呼吸频率有关(r = 0.46,<0.05)。iLCI 的个体内可重复性似乎优于 LCI,但这并没有达到统计学意义(比值=2.2,=0.056)。对 iLCI 的敏感性分析和对 LCI 的回归分析都表明,这些主要取决于 CCP 参数的交互项 σlnCL*(DS/FRC)的形式。总之,LCI(或 iLCI)可能反映了早期 CF 中不同潜在肺部变化的混合体,需要一种多参数方法(如可能的 CCP)来解决。计算心肺图是一种新技术,它由一个用于测量呼吸气体交换的高精度传感器和一个心肺模型组成,用于识别一组患者特定的肺部特征。在这里,我们表明该技术可以改进 CF 患者的肺功能测试的标准临床方法。特别是,结合多个模型参数的方法可以潜在地分离出该疾病中不同的病理变化方面。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e725/10393329/10383794d45e/japplphysiol.00744.2022_f009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e725/10393329/e59cc9919cd5/jappl-00744-2022r01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e725/10393329/0eccfa04cc9d/japplphysiol.00744.2022_f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e725/10393329/d8abed8de2f1/japplphysiol.00744.2022_f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e725/10393329/4c880e6bf28a/japplphysiol.00744.2022_f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e725/10393329/e27e5be32409/japplphysiol.00744.2022_f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e725/10393329/d6fc01e6bed1/japplphysiol.00744.2022_f005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e725/10393329/da8a9e1e57cb/japplphysiol.00744.2022_f006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e725/10393329/bfe7ab0c146b/japplphysiol.00744.2022_f007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e725/10393329/d6e2d88d7313/japplphysiol.00744.2022_f008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e725/10393329/10383794d45e/japplphysiol.00744.2022_f009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e725/10393329/e59cc9919cd5/jappl-00744-2022r01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e725/10393329/0eccfa04cc9d/japplphysiol.00744.2022_f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e725/10393329/d8abed8de2f1/japplphysiol.00744.2022_f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e725/10393329/4c880e6bf28a/japplphysiol.00744.2022_f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e725/10393329/e27e5be32409/japplphysiol.00744.2022_f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e725/10393329/d6fc01e6bed1/japplphysiol.00744.2022_f005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e725/10393329/da8a9e1e57cb/japplphysiol.00744.2022_f006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e725/10393329/bfe7ab0c146b/japplphysiol.00744.2022_f007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e725/10393329/d6e2d88d7313/japplphysiol.00744.2022_f008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e725/10393329/10383794d45e/japplphysiol.00744.2022_f009.jpg

相似文献

1
Computed cardiopulmonography and the idealized lung clearance index, iLCI, in early-stage cystic fibrosis.计算心肺成像和理想化的肺清除指数(iLCI)在早期囊性纤维化中的应用。
J Appl Physiol (1985). 2023 Jul 1;135(1):205-216. doi: 10.1152/japplphysiol.00744.2022. Epub 2023 Jun 1.
2
Repeatability of lung clearance index in infants with cystic fibrosis and recurrent wheeze.囊性纤维化和反复喘息婴儿肺清除指数的可重复性。
Pediatr Pulmonol. 2022 Jul;57(7):1608-1617. doi: 10.1002/ppul.25921. Epub 2022 Apr 26.
3
Altered lung physiology in two cohorts after COVID-19 infection as assessed by computed cardiopulmonography.通过计算心肺摄影评估 COVID-19 感染后两批患者的肺部生理变化。
J Appl Physiol (1985). 2022 Nov 1;133(5):1175-1191. doi: 10.1152/japplphysiol.00436.2022. Epub 2022 Sep 29.
4
Exercise capacity and ventilation inhomogeneity in cystic fibrosis: A cross-sectional study.囊性纤维化患者的运动能力和通气不均:一项横断面研究。
Pediatr Pulmonol. 2020 Feb;55(2):394-400. doi: 10.1002/ppul.24525.
5
A Short extension to multiple breath washout provides additional signal of distal airway disease in people with CF: A pilot study.一项针对 CF 患者的初步研究显示,延长多次呼吸冲洗时间可提供远端气道疾病的更多信号。
J Cyst Fibros. 2022 Jan;21(1):146-154. doi: 10.1016/j.jcf.2021.06.013. Epub 2021 Jul 16.
6
Lung clearance index (LCI) changes after initiation of Elexacaftor/Tezacaftor/Ivacaftor in children with cystic fibrosis aged between 6 and 11 years: The "real-world" differs from trial data.6至11岁囊性纤维化儿童开始使用依列卡福/替扎卡福/依伐卡福后肺清除指数(LCI)的变化:“真实世界”与试验数据不同。
Pediatr Pulmonol. 2024 May;59(5):1449-1453. doi: 10.1002/ppul.26938. Epub 2024 Feb 28.
7
Ventilation Inhomogeneity and Bronchial Basement Membrane Changes in Chronic Neutrophilic Airway Inflammation.慢性中性粒细胞性气道炎症中的通气不均匀性和支气管基底膜改变。
Chest. 2020 Apr;157(4):779-789. doi: 10.1016/j.chest.2019.10.023. Epub 2019 Nov 9.
8
Improvement in Lung Clearance Index and Chest Computed Tomography Scores with Elexacaftor/Tezacaftor/Ivacaftor Treatment in People with Cystic Fibrosis Aged 12 Years and Older - The RECOVER Trial.12岁及以上囊性纤维化患者接受依列卡福/替扎卡福/依伐卡福治疗后肺清除指数和胸部计算机断层扫描评分的改善——RECOVER试验
Am J Respir Crit Care Med. 2023 Nov 1;208(9):917-929. doi: 10.1164/rccm.202308-1317OC.
9
Reflex zone stimulation reduces ventilation inhomogeneity in cystic fibrosis: A randomised controlled cross-over study.反射区刺激可减少囊性纤维化患者通气不均:一项随机对照交叉研究。
Pediatr Pulmonol. 2021 Jun;56(6):1558-1565. doi: 10.1002/ppul.25350. Epub 2021 Mar 13.
10
Abbreviation modalities of nitrogen multiple-breath washout tests in school children with obstructed lung disease.患有阻塞性肺病的学龄儿童氮多次呼吸洗脱试验的缩写方式
Pediatr Pulmonol. 2016 Jun;51(6):624-32. doi: 10.1002/ppul.23339. Epub 2015 Nov 23.

引用本文的文献

1
Effects of biologic therapy on novel indices of lung inhomogeneity in patients with severe type-2 high asthma.生物疗法对重度2型高哮喘患者肺部新的不均匀性指标的影响。
BMJ Open Respir Res. 2025 Feb 8;12(1):e002721. doi: 10.1136/bmjresp-2024-002721.
2
Multiple-breath washout to detect lung disease in patients with inborn errors of immunity.多次呼吸洗脱法用于检测免疫缺陷病患者的肺部疾病。
ERJ Open Res. 2024 Mar 11;10(2). doi: 10.1183/23120541.01019-2023. eCollection 2024 Mar.

本文引用的文献

1
Altered lung physiology in two cohorts after COVID-19 infection as assessed by computed cardiopulmonography.通过计算心肺摄影评估 COVID-19 感染后两批患者的肺部生理变化。
J Appl Physiol (1985). 2022 Nov 1;133(5):1175-1191. doi: 10.1152/japplphysiol.00436.2022. Epub 2022 Sep 29.
2
In asthma positive phase III slopes can result from structural heterogeneity of the bronchial tree.在哮喘中,支气管树的结构异质性可导致第三阶段阳性斜率。
J Appl Physiol (1985). 2022 Apr 1;132(4):947-955. doi: 10.1152/japplphysiol.00687.2021. Epub 2022 Feb 17.
3
Correction of sensor crosstalk error in Exhalyzer D multiple-breath washout device significantly impacts outcomes in children with cystic fibrosis.
纠正 Exhalyzer D 多呼吸冲洗装置中的传感器串扰误差,显著影响囊性纤维化儿童的治疗结果。
J Appl Physiol (1985). 2021 Sep 1;131(3):1148-1156. doi: 10.1152/japplphysiol.00338.2021. Epub 2021 Aug 5.
4
A Phase 3 Open-Label Study of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 through 11 Years of Age with Cystic Fibrosis and at Least One Allele.一项评估 elexacaftor/tezacaftor/ivacaftor 在至少携带一个突变等位基因的囊性纤维化 6 至 11 岁儿童中的疗效和安全性的 3 期、开放性标签研究。
Am J Respir Crit Care Med. 2021 Jun 15;203(12):1522-1532. doi: 10.1164/rccm.202102-0509OC.
5
A dynamic model of the body gas stores for carbon dioxide, oxygen, and inert gases that incorporates circulatory transport delays to and from the lung.一种二氧化碳、氧气和惰性气体的体气存储的动态模型,其中包括到肺和从肺的循环输送延迟。
J Appl Physiol (1985). 2021 May 1;130(5):1383-1397. doi: 10.1152/japplphysiol.00764.2020. Epub 2021 Jan 21.
6
Ventilation heterogeneity in smokers: role of unequal lung expansion and peripheral lung structure.吸烟者通气不均质性:肺扩张不均与周边肺结构的作用。
J Appl Physiol (1985). 2020 Sep 1;129(3):583-590. doi: 10.1152/japplphysiol.00105.2020. Epub 2020 Jul 2.
7
Integrating the multiple breath washout test into international multicentre trials.将多次呼吸冲洗试验纳入国际多中心试验。
J Cyst Fibros. 2020 Jul;19(4):602-607. doi: 10.1016/j.jcf.2019.11.006. Epub 2019 Nov 24.
8
Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele.依伐卡托与泰比卡托和艾克卡托三联复方药物治疗携带单个 F508del 突变的囊性纤维化
N Engl J Med. 2019 Nov 7;381(19):1809-1819. doi: 10.1056/NEJMoa1908639. Epub 2019 Oct 31.
9
Effect of changes in tidal volume on multiple breath washout outcomes.潮气量变化对多次呼吸冲洗结果的影响。
PLoS One. 2019 Jul 3;14(7):e0219309. doi: 10.1371/journal.pone.0219309. eCollection 2019.
10
VX-659-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles.VX-659-泰泽卡托维伐替卡与依伐卡托维在携带一个或两个 Phe508del 等位基因的囊性纤维化患者中的疗效。
N Engl J Med. 2018 Oct 25;379(17):1599-1611. doi: 10.1056/NEJMoa1807119. Epub 2018 Oct 18.